Cargando…

Platelet-Activating Factor Induces Epigenetic Modifications in Human Mast Cells

Ultraviolet (UV) radiation-induced systemic immune suppression is a major risk factor for skin cancer induction. The migration of dermal mast cells from the skin to the draining lymph nodes plays a prominent role in activating systemic immune suppression. UV-induced keratinocyte-derived platelet-act...

Descripción completa

Detalles Bibliográficos
Autores principales:	Damiani, Elisabetta, Puebla-Osorio, Nahum, Gorbea, Enrique, Ullrich, Stephen E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2015
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4648694/ https://www.ncbi.nlm.nih.gov/pubmed/26316070 http://dx.doi.org/10.1038/jid.2015.336

Ejemplares similares

Platelet-activating factor induces cell cycle arrest and disrupts the DNA damage response in mast cells
por: Puebla-Osorio, N, et al.
Publicado: (2015)

Platelet activating factor-induced expression of p21 is correlated with histone acetylation
por: Damiani, Elisabetta, et al.
Publicado: (2017)

Mycobacterium tuberculosis Catalase Inhibits the Formation of Mast Cell Extracellular Traps
por: Campillo-Navarro, Marcia, et al.
Publicado: (2018)

Tryptase Regulates the Epigenetic Modification of Core Histones in Mast Cell Leukemia Cells
por: Alanazi, Sultan, et al.
Publicado: (2021)

Epigenetic histone modification by butyrate downregulates KIT and attenuates mast cell function
por: Gudneppanavar, Ravindra, et al.
Publicado: (2023)

Induction of B-cell lymphoma by UVB Radiation in p53 Haploinsufficient Mice
por: Puebla-Osorio, Nahum, et al.
Publicado: (2011)

Platelet activating factor-induced mast cell degranulation is inhibited by rupatadine, and to a lower extent by levocetirizine and desoratadine, in a mast cell line (LAD-2)
por: Mullol, Joaquim, et al.
Publicado: (2013)

DNA damage-induced cellular senescence is sufficient to suppress tumorigenesis: a mouse model
por: Van Nguyen, Thang, et al.
Publicado: (2007)

Absence of p53-Dependent Apoptosis Combined With Nonhomologous End-Joining Deficiency Leads to a Severe Diabetic Phenotype in Mice
por: Tavana, Omid, et al.
Publicado: (2010)

Intratumoral mast cells promote the growth of pancreatic cancer
por: Ma, Ying, et al.
Publicado: (2013)

Human placental extract suppresses mast cell activation and induces mast cell apoptosis
por: Wu, Tongqian, et al.
Publicado: (2023)

TRAF3 regulates the effector function of regulatory T cells and humoral immune responses
por: Chang, Jae-Hoon, et al.
Publicado: (2014)

Epigenetic and transcriptional control of mast cell responses
por: Monticelli, Silvia, et al.
Publicado: (2017)

Role of platelet activating factor (PAF) on leukocyte-independent plasma extravasation and mast cell activation during endotoxemia
por: Walther, A, et al.
Publicado: (2000)

Platelet-activating Factor, a Molecular Sensor for Cellular Damage, Activates Systemic Immune Suppression
por: Walterscheid, Jeffrey P., et al.
Publicado: (2002)

Physical activity in the prevention of human diseases: role of epigenetic modifications
por: Grazioli, Elisa, et al.
Publicado: (2017)

Pulmonary Pathogen-Induced Epigenetic Modifications
por: Wrede, Dylan, et al.
Publicado: (2023)

SNAP23 is essential for platelet and mast cell development and required in connective tissue mast cells for anaphylaxis
por: Cardenas, Rodolfo A., et al.
Publicado: (2021)

Urate-induced epigenetic modifications in myeloid cells
por: Badii, M., et al.
Publicado: (2021)

Epigenetic Changes in Neoplastic Mast Cells and Potential Impact in Mastocytosis
por: Reszka, Edyta, et al.
Publicado: (2021)

Prognostic value of epigenetic markers for canine mast cell cancer
por: Syed, Shahzar, et al.
Publicado: (2023)

Ku70 Functions in Addition to Nonhomologous End Joining in Pancreatic β-Cells: A Connection to β-Catenin Regulation
por: Tavana, Omid, et al.
Publicado: (2013)

IL-33 and Superantigenic Activation of Human Lung Mast Cells Induce the Release of Angiogenic and Lymphangiogenic Factors
por: Cristinziano, Leonardo, et al.
Publicado: (2021)

Modeling the relationship of epigenetic modifications to transcription factor binding
por: Liu, Liang, et al.
Publicado: (2015)

Epigenetics Modifications and Therapeutic Prospects in Human Thyroid Cancer
por: Catalano, Maria Graziella, et al.
Publicado: (2012)

Yersinia remodels epigenetic histone modifications in human macrophages
por: Bekere, Indra, et al.
Publicado: (2021)

Review on the Role of Epigenetic Modifications in Doxorubicin-Induced Cardiotoxicity
por: Kumari, Himani, et al.
Publicado: (2020)

Epigenetic Transgenerational Modifications Induced by Xenobiotic Exposure in Zebrafish
por: Terrazas-Salgado, Luis, et al.
Publicado: (2022)

Moringa oleifera Improves MAFLD by Inducing Epigenetic Modifications
por: Monraz-Méndez, C. Alejandra, et al.
Publicado: (2022)

Superantigenic Activation of Human Cardiac Mast Cells
por: Varricchi, Gilda, et al.
Publicado: (2019)

Epigenetic regulation of CD34 and HIF1A expression during the differentiation of human mast cells
por: Walczak-Drzewiecka, Aurelia, et al.
Publicado: (2013)

Interleukin-33 Amplifies Human Mast Cell Activities Induced by Complement Anaphylatoxins
por: West, Peter W., et al.
Publicado: (2021)

Bone morphogenetic proteins, activins, and growth and differentiation factors in tumor immunology and immunotherapy resistance
por: Ganjoo, Shonik, et al.
Publicado: (2022)

Effect of Dietary Fiber and Metabolites on Mast Cell Activation and Mast Cell-Associated Diseases
por: Folkerts, Jelle, et al.
Publicado: (2018)

Epigenetic modifications in rheumatoid arthritis
por: Strietholt, Simon, et al.
Publicado: (2008)

Epigenetic Modifications as Therapeutic Targets
por: Kelly, Theresa K, et al.
Publicado: (2010)

Epigenetic modifications in cardiovascular disease
por: Lorenzen, Johan M., et al.
Publicado: (2012)

Epigenetic Modifications and Diabetic Retinopathy
por: Kowluru, Renu A., et al.
Publicado: (2013)

Epigenetic Modifications in Essential Hypertension
por: Wise, Ingrid A., et al.
Publicado: (2016)

Epigenetic modifications and diabetic nephropathy
por: Reddy, Marpadga A., et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_gvtsreljl96ibb5o6ajrf9oid5